Roy Pattipeiluhu
Director, Early-Stage Formulation Process Development, Lnp Technology BioNTech
Multidisciplinary scientist with strong background in chemistry and nanomedicine. Experience with lipid nanoparticle RNA delivery, organic chemistry, proteomics and electron microscopy. Experience in project design, development and technical knowledge. Hands-on attitude, creative, team player, fast-pace learner and flexible, with a strong multicultural background.
Seminars
Wednesday 23rd September 2026
Developing Polymer-Free Lipid Nanoparticles to Simplify Formulation & Improve Safety & Manufacturability of mRNA Delivery
10:00 am
- Evaluate the role of polymers in LNP systems, identify sources of added complexity and toxicity and redesign formulations to maintain performance while simplifying composition
- Optimise lipid-only formulations, improve encapsulation efficiency and delivery performance, reduce variability and enhance manufacturability
- Assess the impact of polymer-free systems on safety, immunogenicity and scalability, enable more robust and clinically viable mRNA delivery platforms
Wednesday 23rd September 2026
Closing Simulation Exercise: Work Through Real World Scenarios to Successfully Take an LNP Therapy from Concept to Clinic
4:00 pm
A practical, end-to-end simulation where participants work through the full lifecycle of an LNP therapy, integrating innovation, CMC and regulatory decision-making to successfully move a candidate toward clinical readiness.
- A practical framework for evaluating LNP designs beyond scientific performance
- Clear understanding of how CMC and regulatory constraints reshape innovation
- Improved ability to make phase-appropriate decisions that accelerate timelines
- Real insight into where most LNP programs fail or stall before clinic
